Verily Health Inc. is set to undergo a significant transformation following a successful funding round of $300 million. This investment will facilitate its transition from an LLC to a corporation, a move that alters Alphabet's stake in the company from controlling to minority. The restructuring is part of Verily's strategic pivot towards artificial intelligence in healthcare.
Chairman and CEO Stephen Gillett emphasized the need for advanced solutions that merge clinical expertise with AI capabilities, aiming to enhance personalized healthcare. The company has a history of innovative projects, including initiatives focused on predicting heart disease through eye scans and establishing an opioid addiction center.
Originally known as Google Life Sciences, Verily rebranded in 2015 when Alphabet was formed. The closure of its medical device division in 2025 likely indicated a shift towards prioritizing AI technologies in its operations.